Partners
MITO2i continues to build a strong community through partnership and engagement. Since its inception MITO2i has attracted and developed partnerships with external organizations, research centres, academic institutions and charities who have a common goal to increase awareness in mitochondrial health and disease to transform mitochondrial medicine.
Clinical Sites
The Hospital For Sick Children (SickKids)
SickKids, Canada’s foremost pediatric research hospital and a leader in mitochondrial research, has forged a collaborative partnership with Mito2i. This collaboration, particularly focused on pediatric mitochondrial research, involves joint efforts with researchers and clinicians affiliated with the University of Toronto. We welcome and encourage further collaboration between our institutions to advance our understanding of mitochondrial diseases.
The University Health Network
The University Health Network (UHN), Canada’s largest health research organization and part of the University of Toronto, plays a pivotal role in facilitating collaborative research with Mito2i. The expansive hospital network of UHN enables Mito2i to engage with a diverse group of researchers in Toronto. Notably, collaborative efforts between Dr. Andreazza, Erika Beroncal at Mito2i, and Marcelo Cypel at UHN have led to a breakthrough method for preserving mitochondrial function during lung transplants.
Sunnybrook Health Sciences Centre
Sunnybrook, Canada’s largest trauma and veterans’ center fully affiliated with the University of Toronto, collaborates with Mito2i in groundbreaking research. Dr. Robert Screaton at Sunnybrook has partnered with Mito2i to investigate the role of mitochondrial DNA in cancer cells, contributing to the development of improved patient-specific therapies.
Sinai Health
Sinai Health, encompassing Mount Sinai Hospital and Hennick Bridgepoint Hospital, is affiliated with the University of Toronto. Mito2i seeks to promote collaboration between Sinai Health and its organization, fostering joint efforts to advance mitochondrial research and address related medical challenges.
St. Michael's Hospital (Division of Unity Health)
St. Michael’s Hospital, a tertiary care teaching hospital affiliated with the University of Toronto, serves a diverse population in Toronto’s downtown core. Mito2i acknowledges the unique challenges and opportunities presented by this dynamic environment and aims to foster collaboration with researchers and clinicians associated with St. Michael’s.
Centre For Addictions and Mental Health (CAMH)
The Centre for Addiction and Mental Health (CAMH), Canada’s foremost mental health and addictions facility, maintains a longstanding collaboration with Mito2i. Dr. Ana Andreazza, founder and academic director of Mito2i, serves as a collaborator scientist at CAMH, where researchers explore the link between mitochondrial dysfunction and mental health disorders such as depression, bipolar disorder, and schizophrenia.
Holland Bloorview Kids Rehabilitation Hospital
Holland Bloorview, specializing in pediatric rehabilitation, has collaborated with Mito2i, providing valuable insights into the role of mitochondria in Autism. Mito2i has also supported researchers at Holland Bloorview in their efforts to advance understanding in this area.
Baycrest Health Sciences
Baycrest, a research hospital specializing in care for the elderly and affiliated with the University of Toronto, is invited to collaborate with Mito2i. The focus of collaboration includes research on age-related disorders such as Alzheimer’s, dementia, and Parkinson’s.
Foundations and Organizations
MitoCanada
MitoCanada, the premier mitochondrial foundation in Canada, is dedicated to funding research and raising awareness for mitochondrial diseases. Mito2i and MitoCanada collaborate on research projects, including funding for therapies related to Alzheimer’s, Autism Spectrum Disorder, and investigations into the link between mitochondrial dysfunction and psychiatric issues.
Thomas Constantine Zachos
Thomas Constantine Zachos, a Canadian author and patient advocate, has partnered with Mito2i to raise awareness of mitochondrial disease. Together, they have organized fundraisers at the University of Toronto to amplify awareness within the scientific and academic communities.
My Mito Mission
My Mito Mission, a British charitable foundation, aims to empower individuals with mitochondrial disease by raising awareness, donating research funds, and providing support. Recognizing the broad impact of mitochondrial dysfunction, My Mito Mission endeavors to expand research and public awareness linking mitochondria to various diseases.
The Lily Foundation
The Lily Foundation, based in the UK, collaborates extensively with Mito2i and other international organizations. Their joint mission involves shifting the narrative surrounding mitochondria from a niche area to mainstream scientific discussions. Lily and Mito2i have co-funded studies focusing on mitochondria and neuropsychiatric diseases.
Toronto Dementia Research Alliance (TDRA)
The Toronto Dementia Research Alliance (TDRA), established in 2012, strategically collaborates with institutions including Baycrest, CAMH, Ontario Shores, Sunnybrook, Unity Health, and UHN. Mito2i collaborates with TDRA to deepen our understanding of the role mitochondria play in Alzheimer’s disease.
Ted Rogers Centre for Health Research
The Ted Rogers Center for Heart Research, dedicated to improving heart health through genetics and regenerative medicine, collaborates with Mito2i. This collaboration includes funding a seed grant for research exploring the link between mitochondria and heart failure.
Centre for Commercialization of Regenerative Medicine (CCRM)
The Centre for Commercialization of Regenerative Medicine (CCRM) collaborates with research institutes to accelerate the commercialization of regenerative medicine technologies. CCRM has partnered with Mito2i to promote research on Mitochondrial Dysfunction for the Discovery and Development of Novel CNS Therapies in Rare and Neurodegenerative Diseases..
Medicine By Design
Medicine by Design (MBD), a strategic hub at the University of Toronto focusing on regenerative medicine and cell therapy, collaborates with Mito2i. Together, they work to advance research and technology in mitochondrial transplantation.
Wellcome Centre for Mitochondrial Research
The Wellcome Centre for Mitochondrial Research, based at Newcastle University in the UK, aims to translate scientific advances into revolutionary treatments for mitochondrial health. Mito2i collaborates with the Wellcome Center, hosting an exchange program for trainees from each other’s institutes and organizing workshops.
Interested in becoming a partner? Contact us for more information!
